Jupiter Neurosciences Expands CNS Pipeline with ALA-002 Licensing Deal Worth Up to $100M The deal adds a differentiated psychedelic asset to Jupiter’s CNS pipeline. Credit: Jupiter Neurosciences Subscribe now Already have an account? Sign in.
